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 There is often a delay between the occurrence of medical events and the event being 19 
entered in a patient’s primary care record. 20 
 In studies using primary care databases, these delays will result in censoring of events 21 
towards the end of follow up. 22 
 The problem is more apparent for events typically presenting/diagnosed outside primary 23 
care. 24 
 We illustrate a graphical method to identify the problem and determine a point prior to the 25 
end of data collection to censor follow up at. 26 
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Abstract 1 
 2 
Purpose: Studies using primary care databases often censor follow up at the date data is last 3 
collected from clinical computer systems (LCD). We explored whether this results in the selective 4 
exclusion of events entered in the electronic health records after their date of occurrence i.e. 5 
backdated events.   6 
 7 
Methods: We used data from The Health Improvement Network (THIN). Using two versions of the 8 
database we identified events that were entered into a later (THIN14), but not an earlier version of 9 
the database (THIN13) and investigated how the number of entries changed as a function of time 10 
since LCD. Times between events and the dates they were recorded were plotted as a function of 11 
time since the LCD in an effort to determine appropriate points at which to censor follow up.   12 
 13 
Results: There were 356 million eligible events in THIN14 and 355 million eligible events in THIN13. 14 
When comparing the two datasets, the proportion of missing events in THIN13 was highest in the 15 
month prior to the LCD (9.6%), decreasing to 5.2% at 6 months and 3.4% at 12 months. The 16 
proportion of missing events was largest for events typically diagnosed in secondary care such as 17 
neoplasms (28% in the month prior to LCD) and negligible for events typically diagnosed in primary 18 
care such as respiratory events (2% in the month prior to LCD).   19 
 20 
Conclusions:  Studies using primary care databases, particularly those investigating events typically 21 
diagnosed outside primary care, should censor follow up prior to the LCD to avoid underestimation 22 
of event rates. 23 
 24 
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Introduction 1 
Primary care databases such as the Clinical Practice Research Data Link (CPRD) and The Health 2 
Improvement Network (THIN) in the UK have become increasingly popular data sources for 3 
epidemiological and health care research.1 However, as such databases are based on data that are 4 
entered for clinical management, rather than research, further work is needed to investigate best 5 
practice in the conduct and reporting of research carried out using them.2 6 
As suggested by its name, primary care is commonly the initial point of contact between individuals 7 
and their healthcare system. As a result, a large amount of information about a patient is collected in 8 
primary care computer systems. Events which occur outside primary care, such as diagnoses made in 9 
secondary care may be reported to primary care after they have occurred e.g. via hospital discharge 10 
letters. Primary care computer systems typically allow such records to be entered into a patient’s 11 
record alongside a backdated date of event occurrence.  12 
When carrying out research using primary care databases, in the absence of a competing event (e.g. 13 
death, moving healthcare provider etc.), the date data is last uploaded from clinical computer 14 
systems to the database provider is typically used to censor follow up. As illustrated in Figure 1, 15 
censoring at the dates data are last collected from clinical computer systems, means that some 16 
events which have occurred may not yet have been reported to the primary care practice and 17 
entered into the clinical computer systems at the time of data collection. As a consequence the 18 
incidence and prevalence of specific diseases/conditions may be underestimated as follow up 19 
approaches the censoring date. 20 
In this study we used a UK primary care database to examine the extent to which censoring at the 21 
date data is last collected results in the selective exclusion of backdated events and investigate a 22 
generally applicable method to identify and mitigate the problem in research using electronic health 23 
records. 24 
 25 
Methods 1 
Data source 2 
We used data from The Health Improvement Network (THIN), which collects data from general 3 
practices (family practices) in the United Kingdom using Vision Software3. THIN is an electronic 4 
healthcare database containing the anonymised primary care medical records of more than 12 5 
million individuals, more than 3.5 million of whom are currently actively providing data. Practice data 6 
available in the database includes the date a practice first computerised their records and the date a 7 
practice started to use Vision software. As data collection is ongoing, updated versions of the 8 
database are created on a monthly basis. Each time a new version is created information on when 9 
data was last collected from each practice (last collection date; LCD) is updated. Additional practice 10 
level metrics can be derived and used to define the date a practice begins recording acceptable levels 11 
of patient data.4,5  12 
Patient data routinely available in the database include registration and demographic details, 13 
diagnoses and symptoms including those leading to hospital admissions, immunisations, 14 
pregnancies, laboratory tests, referrals to specialists, prescriptions issued by the General Practitioner, 15 
hospital discharge and clinic summaries and deaths. Clinical events and other patient characteristics 16 
in THIN are recorded as Read codes which are structured in a medical records table. There are 17 
currently over 100,000 Read codes each of which is associated with a short description of varying 18 
specificity. Read codes are arranged into mono-hierarchical chapters representing different clinical 19 
areas (Box 1).6,7 20 
In general practices using Vision software, a system date is automatically entered on the computer 21 
when an event is recorded in a patient’s electronic health record. However, the practice staff creating 22 
the record can enter a date on which the event they are recording is deemed to have occurred, called 23 
the event date. As outlined in the introduction this facilitates the backdating of events which occur 24 
outside general practice, for example, events that occurred before a patient registered with the 25 
general practice or events presenting in secondary or tertiary care such as cancer diagnoses.    26 
In order to assess whether censoring at LCD results in the exclusion of events from the primary care 27 
record, this study took the novel approach of utilising two versions of the database, created 28 
approximately one year apart. In the first dataset (THIN 13) data lock occurred in January 2013 29 
therefore the maximum possible LCD was in January 2013, while in the second dataset (THIN 14) 30 
data lock occurred in January 2014 therefore the maximum possible LCD was in January 2013. By 31 
excluding any events from both databases where the event date is greater than the LCDs recorded in 32 
THIN 13, we were able to carry out our analysis based on the premise that THIN 13 contains the data 33 
typically available to a research team conducting a study in a given year, and that the remaining THIN 34 
14 data now simply represents an updated version of THIN 13 in which many events with an event 35 
date earlier than, but a system date greater than the THIN 13 LCD can now be observed. (Figure 2).  36 
In both databases we focused on records which were made after 1 January 2000 and event dates 37 
which were at least 365 days after a patient had registered with the general practice. Further we only 38 
used information recorded after a practice had started using Vision software for patient 39 
management and after data recording in a practice reached acceptable levels.  40 
 1 
 2 
Chapter Contents 
0 Occupations  
1 History/symptoms 
2 Examination/signs 
3 Diagnostic procedures  
4 Laboratory procedures 
5 Radiology/medical physics 
6 Preventative procedures 
7 Operations and procedures 
8 Other therapeutic procedures 
9 Administration 
A Infectious/parasitic diseases 
B Neoplasms  
C Endocrine/metabolic 
D Blood diseases 
E Mental disorders 
F Nervous system/senses 
G Circulatory system 
H Respiratory system 
J Digestive system 
K Genito-urinary system 
L Pregnancy/childbirth/puerperium 
M Skin/subcutaneous tissue 
N Musculoskeletal 
P Congenital anomalies 
Q Perinatal conditions 
R Ill-defined conditions/working diagnoses 
S Injury/poisoning 
T Causes of injury/poisoning 
U External causes of morbidity and mortality 
Z Unspecified conditions 
Box 1. Read codes are structured in a mono-hierarchical system within the following chapters.6,7 3 
 4 
 5 
 6 
 7 
Data analysis 1 
First, we calculated the total number of events recorded in the medical records table of THIN 13 and 2 
THIN 14 using a code from any of the Read code chapters (Box 1). As THIN 14 is considered the more 3 
complete dataset, we estimated the proportion of missing records in THIN 13 as the difference in the 4 
number of eligible events in THIN13 and THIN14 and expressed this as a percentage of the total 5 
number of eligible events in THIN 14. This percentage was described as a function of time between 6 
the event date and the THIN 13 LCD.  7 
Subsequently, we calculated the same statistics for each individual Read code chapter and present 8 
the results for events from chapters B (neoplasms), G (circulatory system) M (skin/subcutaneous 9 
tissue) and H (respiratory system). As events in chapters B and G typically relate to cancer and 10 
cardiovascular diagnoses we suspect these are more likely to occur in secondary or tertiary care than 11 
events in chapters M and H, which are often diagnoses that can be made in the GP practice. 12 
We then tested a graphical method that could potentially be used to identify and mitigate the 13 
problem in a normal study setting where two datasets are not typically available for comparison. This 14 
method is based on the assumption that at a certain point prior to the LCD (e.g. 5 years) the 15 
proportion of backdated events that are censored becomes negligible. The distribution of time 16 
between system and event dates for events occurring more than 5 years before the LCD can then be 17 
used to determine the probability that an event would be recorded at different points prior to the 18 
LCD. By choosing an 'acceptable' probability one can determine a point prior to the LCD at which to 19 
censor follow up. Cumulative incidence plots will be used to describe the time between system and 20 
event dates for events occurring greater than 5 years before the LCD for each of the four Read code 21 
chapters, B, G, H and M. 22 
All data management and analysis was carried out in Stata 13.  23 
 24 
 25 
Results 1 
There were 355.96 million eligible events recorded in the THIN 13 dataset and 356.86 million events 2 
in the THIN 14 dataset during the same time period, a difference of 901,955 events. The proportion 3 
of events that were missing in THIN 13 was highest in the month prior to the LCD (9.6%) decreasing 4 
to 5.2% in the 6 months prior and 3.4% in the twelve months prior (Table 1). Expressed as a 5 
proportion of the overall number of events recorded in THIN 14 during the entire study period, 6 
0.01%, 0.1%  and 0.1% of codes were missing at 1, 6 and 12 months prior to the LCD. 7 
The proportion of entries from specific Read code chapters differed. Thus, we observed that 27.7% of 8 
neoplasm events were missing in the first month prior to the LCD in THIN 13 (Table 1, figure 3). At 6 9 
months and 12 months prior to the LCD the proportion of missing neoplasm records was 7.6% and 10 
4.5% respectively. For circulatory system events the figures were 18.2%, 6.8% and 4.5%.  In contrast, 11 
relatively few skin condition and respiratory events were missing in the same time periods (Table 1, 12 
figure 3).  13 
Expressing these Read code chapter specific results as a proportion of the overall number of events 14 
in each of these chapters during the study period, the proportion of missing events at 1, 6 and 12 15 
months prior to the LCD respectively was: 0.2%, 0.4%  and 0.4% of neoplasm events and 0.1%, 0.2% 16 
and 0.3% of circulatory system events. 17 
Figure 4 contains Read code chapter specific plots showing the distribution of time between event 18 
and system dates for first events occurring more than 5 years prior to the LCD. Among events 19 
occurring more than 5 years ago, 70% of circulatory system events, 67% of neoplasm events, 93% of 20 
skin events and 92% of respiratory events have the same event and system date, 81%, 84%, 96% and 21 
97% of these events had <30 days difference between their event and system dates and 85%, 90%, 22 
97% and 98% of events had <120 days difference between their event and system dates. Table S1 23 
(supplementary data) shows the 50th, 75th, 90th and 95th percentile of time between the system and 24 
event dates for different Read codes (grouped at 2 digits); considerable variation within Read code 25 
chapters is apparent. 26 
 27 
Discussion 28 
This study illustrates that when using UK primary care databases, censoring at the last collection date 29 
may result in the selective exclusion of events that occur before, but are recorded after the last 30 
collection date. This appears to be a particular issue for events typically presenting/diagnosed in 31 
secondary care such as cancers and circulatory system events. 32 
The main implication of these findings is that studies are likely to underestimate incidence and 33 
prevalence rates towards the end of data collection. The extent to which rates are underestimated 34 
will depend on what proportion of the numerator the missing events represent; the impact is likely 35 
to be largest for rates estimated for shorter periods near the end of data collection. Studies which 36 
compare incidence rates in two groups as a means of determining the safety or effectiveness of a 37 
treatment must consider whether censoring is informative (i.e. whether any underestimation is more 38 
likely to affect one group than another). For example, if individuals exposed to a drug ‘X’ of interest 39 
were under the care of a specialist and therefore more likely to present to them with an adverse 40 
event, while unexposed individuals or those exposed to a drug ‘Y’ were not under the care of a 1 
specialist and therefore more likely to present directly to their GP with the same event, then it is 2 
more likely that there will be a difference in the system and event dates of adverse events in those 3 
exposed to drug X.  4 
We suggest that the most suitable approach to deal with the issue is to determine an appropriate 5 
amount of time prior to the LCD to censor follow up at. The appropriate amount of time could be 6 
determined in a number of ways, most simply by carrying out analyses which test the sensitivity of 7 
results to censoring at a variety of time points (e.g. 1 month, 6 months and 12 months) prior to the 8 
LCD. We have illustrated an alternative, relatively simple graphical approach to determine an 9 
appropriate amount of time prior to the LCD to censor at using a single dataset. This method uses 10 
the distribution of times between event and system dates for events recorded in a period relatively 11 
unaffected by the censoring. This plot can be used to estimate the probability that an event will be 12 
observed at different points prior to the LCD, by choosing a cut-off at which the probability is 13 
deemed acceptable one can determine a period prior to the LCD at which to censor. For example, the 14 
probability of a respiratory or skin event not being recorded is less than 10% at any time prior to the 15 
LCD for respiratory and skin events but for neoplasm and circulatory events the probability an event 16 
is not recorded is ~30% on the day of the LCD, 15% and 18% respectively a month prior to the LCD 17 
and 10% and 14% respectively in the three months prior to the LCD. A limitation of this approach is 18 
that it assumes there are no secular trends in recording delays. 19 
This study sought to provide a broad investigation of the issue across the entire database and 20 
therefore results are primarily presented for entire Read code chapters. As illustrated in Table S1, the 21 
relationships between system and event dates may vary for subsets of events within each of these 22 
chapters. For example, cancers which can be detected more rapidly or that are managed in general 23 
practice may have shorter durations between event and system dates than those which are more 24 
complicated. We would therefore suggest that while our results in Table S1 can be used as a guide, in 25 
specific studies the diagnostic plot described above should be created for the specific events under 26 
study. 27 
While this study has focused on primary care databases, other electronic healthcare databases in 28 
which events can be backdated may also suffer from missing events in the period approaching the 29 
end of data collection. 30 
Diagnostic plots such as those described by Lewis et al8 have become a routine step in designing 31 
electronic healthcare database studies, our results suggest that diagnostic plots of time between 32 
event and system dates as a function of time since LCD should also be incorporated as a routine step 33 
in this phase of studies conducted in UK primary care databases, and potentially other databases 34 
which allow for the backdating of events. At a minimum, studies using these databases to investigate 35 
diagnoses typically made in secondary or tertiary care should test the sensitivity of their results to 36 
censoring at a series of time points earlier than the LCD. 37 
 38 
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Table 1. Numbers of events in THIN14 and THIN13 in different periods before the 
last collection date. 
  
n events 
THIN2013 
n events 
THIN2014 
n(%) events missing 
THIN2013* 
All events 
     
1 month before LCD 3503886 3166627 337259 (9.63) 
6 months before LCD 7184831 6808246 376585 (5.24) 
12 months before LCD 11599088 11207025 392063 (3.38) 
Ever before LCD 356859321 355957326 901995 (0.25) 
Neoplasm events 
1 month before LCD 731100 725966 5134 (0.70) 
6 months before LCD 4630 3348 1282 (27.69) 
12 months before LCD 35639 32932 2707 (7.6) 
Ever before LCD 71737 68490 3247 (4.53) 
Circulatory system events 
1 month before LCD 13383 10944 2439 (18.22) 
6 months before LCD 91386 85183 6203 (6.79) 
12 months before LCD 189672 181094 8578 (4.52) 
Ever before LCD 2756581 2733288 23293 (0.84) 
Skin condition events 
1 month before LCD 46719 45427 1292 (2.77) 
6 months before LCD 340150 337673 2477 (0.73) 
12 months before LCD 693288 690411 2877 (0.41) 
Ever before LCD 6935895 6930469 5426 (0.08) 
Respiratory events 
1 month before LCD 84959 82866 2093 (2.46) 
6 months before LCD 372311 367741 4570 (1.23) 
12 months before LCD 776951 770814 6137 (0.79) 
Ever before LCD 8800018 8784045 15973 (0.18) 
*n events in THIN2014 in each period used as the denominator for % calculation 
1 
 1 
 2 
Figure 1: Schematic description of the censoring issue. In order to be recorded in the database, the entry 3 
date for an event must occur before the date data is last collected. As illustrated in Panel A, this should not be 4 
a problem for events diagnosed in primary care as the event date and entry dates will typically be the same 5 
(or very close together). However, Panel B illustrates that for events diagnosed in secondary or tertiary care, 6 
where the entry date and event date will typically be further apart, the entry date may occur after the date 7 
data are last collected from a clinical computer systems and therefore not be observed. 8 
 1 
Figure 2: Reasoning for comparing two datasets in the analysis. Panel A shows a hypothetical sample of 2 
data available in THIN13. Events in patients 4, 6 and 7 are not recorded in THIN13 as their system date 3 
occurs after the practice LCD. Panel B shows data for the same patients in THIN14. System dates for events 4 
in patients 4, 6 and 7 occur before the THIN14 LCD therefore their event dates are recorded in this dataset 5 
even if follow up is censored at the THIN13 LCD.  6 
 1 
Figure 3 Line plots showing the difference in the number of events recorded in THIN2013 and THIN2014 in each month 2 
prior to the THIN2013 LCD as a proportion of the total number of events in the 2014 THIN dataset in that month, Plots 3 
shown for four different types of event: neoplasm (panel a) circulatory (panel b) skin (panel c) and respiratory conditions 4 
(panel d).  5 
 1 
 2 
Figure 4 Cumulative incidence plots showing the distribution of time between event and system dates for first events 3 
occurring more than 5 years prior to the LCD for four different types of event: neoplasm (panel a) circulatory system (panel 4 
b) skin (panel c) and respiratory conditions (panel d). Plots truncated at 24 months.5 
Supplementary data 1 1 
Supplementary to the main analysis which focused on four broad Read code chapters, the below table provides results for more specific Read 2 
code categories (categorised at 2 digit Read code level). That is, for events occurring more than 5 years prior to the LCD, we present the total 3 
number of events for each Read code category and the 50th, 75th, 90th and 95th percentiles of the distribution of time between system and 4 
event dates for each event type.  5 
These data can be interpreted similarly to the data presented in Figure 4 of the manuscript in that for the 2 digit Read code category “B7”, 6 
which contains codes related to benign neoplasms, there were 142,875 events occurring more than 5 years before the LCD, and the probability 7 
of a missing event was less than or equal to 10% 14 days before the LCD and as low as 5% (or less) 32 days before the LCD. For Read code 8 
category “B4” which contains code related to genitourinary neoplasms there were 16,655 events occurring more than 5 years before the LCD, 9 
and the probability of a missing event was 25% 13 days before the LCD, 10% 110 days before the LCD and 5% more than 1 year (391 days) 10 
before the LCD. 11 
Note that categories with less than 5 events are marked “NA” as we cannot report results for categories containing so few events. 12 
 13 
2 digit 
Read 
code 
  Total 
number 
of events 
Days between system and 
event date 
  p50 p75 p90 p95 
Infectious/parasitic diseases 
A0 Intestinal infectious diseases 21,039 0 0 2 10 
A1 Tuberculosis 1,302 0 17 49 323 
A2 Zoonotic bacterial diseases 13 0 0 0 18 
A3 Other bacterial diseases 8,542 0 0 16 42 
A4 Poliomyelitis & other non-arthropod-borne viral diseases-CNS 67 0 15 36 92 
A5 Viral diseases with exanthem 125,480 0 0 0 7 
A6 Arthropod-borne viral diseases 10 0 0 7 7 
A7 Other viral and chlamydial diseases 317,178 0 0 0 3 
A8 Rickettsioses and other arthropod-borne diseases 319 0 3 19 58 
A9 Syphilis and other venereal diseases 834 0 0 14 48 
AA Other spirochaetal diseases 67 0 0 8 12 
AB Mycoses 460,321 0 0 0 0 
AC Helminthiases 9,269 0 0 0 0 
AD Other infectious and parasitic diseases 60,586 0 0 0 7 
AE Late effects of infectious and parasitic diseases 19 0 0 11 18 
Ay Other specified infectious or parasitic diseases 19 0 11 193 521 
Az Infectious and parasitic diseases NOS NA NA NA NA NA 
Neoplasms      
B0 Malignant neoplasm of lip, oral cavity and pharynx 657 0 14 93 407 
B1 Malignant neoplasm of digestive organs and peritoneum 10,736 1 15 61 213 
B2 Malig neop of respiratory tract and intrathoracic organs 6,990 1 11 36 106 
B3 Malig neop of bone, connective tissue, skin and breast 53,366 6 21 102 523 
B4 Malignant neoplasm of genitourinary organ 16,655 0 13 110 391 
B5 Malignant neoplasm of other and unspecified sites 5,956 0 7 29 82 
B6 Malignant neoplasm of lymphatic and haemopoietic tissue 10,900 7 20 146 473 
B7 Benign neoplasms 142,875 0 0 14 32 
B8 Carcinoma in situ 9,171 0 14 35 110 
B9 Neoplasms of uncertain behaviour 4,354 5 14 43 289 
BA Unspecified nature neoplasm 59 0 14 28 54 
BB [M]Morphology of neoplasms 42,748 6 18 51 195 
By Neoplasms otherwise specified 80 7 18 67 249 
Bz Neoplasms NOS 3 16 37 37 37 
Endocrine/metabolic     
C0 Disorders of thyroid gland 121,826 0 0 64 949 
C1 Other endocrine gland diseases 308,420 0 0 49 797 
C2 Nutritional deficiencies 16,004 0 0 0 20 
C3 Other metabolic and immunity disorders 306,222 0 0 4 42 
Cy Endocrine, nutritional, metabolic or immunity disorders OS NA NA NA NA NA 
Cz Endocrine, nutritional, metabolic or immunity disorder NOS NA NA NA NA NA 
Blood diseases     
D0 Deficiency anaemias 79,534 0 0 6 28 
D1 Haemolytic anaemias 2,491 3 17 62 349 
D2 Aplastic and other anaemias 23,961 0 0 14 41 
D3 Clotting and bleeding disorders 5,429 0 12 39 228 
D4 White blood cell and other blood disorders 6,357 0 6 23 95 
Dy Other specified disorders of blood or blood forming organ 248 0 0 0 23 
Dz Blood/blood forming organ NOS NA NA NA NA NA 
Mental disorders     
E0 Organic psychotic conditions 18,539 0 0 13 41 
E1 Non-organic psychoses 95,386 0 0 9 118 
E2 Neurotic, personality and other nonpsychotic disorders 1,141,400 0 0 4 184 
E3 Mental retardation 185 0 14 1381 1381 
Eu [X]Mental and behavioural disorders 297,087 0 0 42 386 
Ey Other specified mental disorders NA NA NA NA NA 
Ez Mental disorders NOS 12 0 0 0 7 
Nervous system/senses     
F0 Inflammatory diseases of the central nervous system 1,042 0 2 26 66 
F1 Hereditary and degenerative diseases of the CNS 53,302 0 0 15 45 
F2 Other central nervous system disorders 223,687 0 0 11 47 
F3 Peripheral nervous system disorders 84,596 0 0 20 55 
F4 Disorders of eye and adnexa 1,017,805 0 1 22 61 
F5 Diseases of the ear and mastoid process 1,540,049 0 0 0 6 
Fy Other specified diseases of nervous system or sense organ 9,382 0 0 14 35 
Fz Nervous system or sense organ disease NOS NA NA NA NA NA 
Circulatory system     
G0 Acute rheumatic fever 40 0 7 35 111 
G1 Chronic rheumatic heart disease 1,505 9 26 90 472 
G2 Hypertensive disease 502,416 0 0 1 304 
G3 Ischaemic heart disease 246,952 0 5 54 660 
G4 Pulmonary circulation diseases 4,105 1 18 106 621 
G5 Other forms of heart disease 218,435 0 12 85 610 
G6 Cerebrovascular disease 65,872 0 14 124 708 
G7 Arterial, arteriole and capillary disease 67,205 0 7 38 278 
G8 Vein, lymphatic and circulatory diseases NOS 308,995 0 0 8 27 
G9 Vascular calcification NA NA NA NA NA 
Gy Other specified diseases of circulatory system NA NA NA NA NA 
Gz Circulatory system disease NOS 6 2076 2118 2129 2129 
Respiratory system     
H0 Acute respiratory infections 3,873,071 0 0 0 1 
H1 Other upper respiratory tract diseases 407,937 0 0 0 7 
H2 Pneumonia and influenza 44,547 0 0 13 34 
H3 Chronic obstructive pulmonary disease 572,282 0 0 35 630 
H4 Lung disease due to external agents 1,093 0 17 75 750 
H5 Other respiratory system diseases 20,758 0 6 26 66 
Hy Other specified diseases of respiratory system 28 0 0 0 0 
Hz Respiratory system diseases NOS 29 0 0 0 9 
Digestive system     
J0 Oral cavity, salivary glands and jaw diseases 108,740 0 0 0 8 
J1 Oesophageal, stomach and duodenal diseases 460,642 0 0 8 34 
J2 Appendicitis and other disorders of the appendix 218 0 12 47 242 
J3 Hernia of abdominal cavity 81,996 0 8 28 92 
J4 Noninfective enteritis and colitis 74,149 0 1 21 64 
J5 Other diseases of the intestines and peritoneum 385,628 0 0 14 42 
J6 Liver, biliary, pancreas + gastrointestinal diseases NEC 64,977 0 14 50 258 
Jy Other specified diseases of digestive system 6 12 24 46 46 
Jz Digestive system diseases NOS NA NA NA NA NA 
Genito-urinary system     
K0 Nephritis, nephrosis and nephrotic syndrome 24,624 0 13 45 190 
K1 Other urinary system diseases 737,010 0 0 2 14 
K2 Male genital organ diseases 182,469 0 0 10 31 
K3 Disorders of breast 124,394 0 0 11 29 
K4 Female pelvic inflammatory diseases 42,799 0 0 0 11 
K5 Other female genital tract disorders 697,672 0 0 1 17 
Ky Other specified diseases of genitourinary system 8 0 0 15 15 
Kz Genitourinary disease NOS NA NA NA NA NA 
Pregnancy/childbirth/puerperium    
L0 Pregnancy with abortive outcome 27,323 5 16 106 754 
L1 Pregnancy complications 26,542 0 0 11 33 
L2 Risk factors in pregnancy 5,743 9 21 84 684 
L3 Complications occurring during labour and delivery 3,980 7 17 50 253 
L4 Complications of the puerperium 1,109 0 0 0 6 
L5 Maternal care for fetus NA NA NA NA NA 
Ly Complications of pregnancy,childbirth or the puerperium OS 1,129 6 10 25 51 
Lz Complications of pregnancy,childbirth and the puerperium NOS NA NA NA NA NA 
Skin/subcutaneous tissue   
M0 Skin and subcutaneous tissue infections 676,370 0 0 0 4 
M1 Other skin and subcutaneous tissue inflammatory conditions 1,228,714 0 0 0 7 
M2 Other skin and subcutaneous tissue disorders 1,349,495 0 0 0 13 
My Other specified diseases of skin or subcutaneous tissue 123 0 0 1 12 
Mz Skin and subcutaneous tissue disease NOS 2,706 0 0 0 0 
Musculoskeletal     
N0 Arthropathies and related disorders 1,218,997 0 0 6 26 
N1 Vertebral column syndromes 1,189,506 0 0 1 12 
N2 Rheumatism, excluding the back 1,984,830 0 0 0 9 
N3 Osteopathy/chondropathy/acquired musculoskeletal deformity 83,750 0 0 28 228 
Ny Musculoskeletal or connective tissue diseases OS 6,631 0 0 24 120 
Nz Musculoskeletal and connective tissue diseases NOS 137 0 0 0 2 
Congenital anomalies     
P0 Anencephalus and similar anomalies NA NA NA NA NA 
P1 Spina bifida 225 0 19 55 490 
P2 Other nervous system congenital anomalies 143 12 30 62 151 
P3 Congenital eye anomalies 460 9 22 52 100 
P4 Ear, face and neck congenital anomalies 834 0 2 32 132 
P5 Bulbus cordis and cardiac septal closure anomalies 1,623 14 33 183 918 
P6 Other congenital heart anomalies 565 6 24 71 292 
P7 Other congenital circulatory system anomalies 627 10 38 303 1106 
P8 Respiratory system congenital anomalies 149 2 20 151 364 
P9 Cleft palate and lip 142 8 34 90 267 
PA Other congenital upper alimentary tract anomalies 1,147 0 14 41 160 
PB Other congenital digestive system anomaly 252 3 24 50 120 
PC Congenital genital organ anomalies 2,485 0 14 41 126 
PD Urinary system congenital anomalies 1,609 6 19 53 481 
PE Certain congenital musculoskeletal deformities 1,592 0 12 35 87 
PF Other congenital limb anomalies 925 0 9 30 76 
PG Other congenital musculoskeletal anomalies 765 4 22 60 248 
PH Congenital integument anomalies 2,496 0 8 27 57 
PJ Chromosomal anomalies 1,012 0 19 50 193 
PK Other and unspecified congenital anomalies 1,164 4 20 60 253 
Py Other specified congenital anomaly NA NA NA NA NA 
Pz Congenital anomaly NOS NA NA NA NA NA 
Perinatal conditions     
Q0 Fetus/neonate affected by maternal problem unrelated to preg 7 6 66 797 797 
Q1 Disorders due to slow fetal growth, low and high birthweight 21 10 25 186 3640 
Q2 Birth trauma, asphyxia and hypoxia 44 0 9 55 263 
Q3 Fetus and newborn respiratory conditions 140 0 0 0 10 
Q4 Other perinatal conditions 300 0 11 43 99 
Qy Other specified perinatal conditions NA NA NA NA NA 
Qz Perinatal conditions NOS NA NA NA NA NA 
Ill-defined conditions/working diagnoses   
R0 [D]Symptoms 2,091,921 0 0 3 14 
R1 [D]Nonspecific abnormal findings 110,299 0 0 0 21 
R2 [D]Cause of morbidity and mortality unsure and ill-defined 45,432 0 0 3 20 
R3 [D]Specific abnormal findings 24 0 0 10 20 
Ry [D]Other specified symptoms, signs or ill-defined conditions 1,265 0 0 12 153 
Rz [D]Symptoms, signs and ill-defined conditions NOS NA NA NA NA NA 
Injury/poisoning     
S0 Fracture of skull 1,620 3 14 40 139 
S1 Fracture of neck and trunk 3,377 0 9 41 132 
S2 Fracture of upper limb 41,641 8 20 58 252 
S3 Fracture of lower limb 29,969 9 22 69 266 
S4 Dislocations and subluxations 6,637 4 15 39 103 
S5 Sprains and strains of joints and adjacent muscles 137,911 0 0 7 18 
S6 Intracranial injury excluding those with skull fracture 20,619 3 9 23 48 
S7 Internal injury of chest, abdomen and pelvis 47 0 15 62 115 
S8 Open wound of head, neck and trunk 18,082 0 7 15 28 
S9 Open wound of upper limb 4,195 3 9 21 43 
SA Open wound of lower limb 4,509 0 0 8 18 
SB Injury to blood vessels 21 0 0 1 7 
SC Late effects injury/poisoning/toxic effects/external causes 495 0 0 4 17 
SD Superficial injury 27,448 0 0 6 13 
SE Contusion (bruise) with intact skin 22,078 0 0 9 18 
SF Crushing injury 1,716 0 0 10 21 
SG Foreign body (FB) in orifice 2,106 3 9 21 34 
SH Burns 5,708 0 0 9 21 
SJ Nerve and spinal cord injuries 288 0 4 16 31 
SK Traumatic complications and unspecified injuries 140,201 0 6 15 28 
SL Poisoning 16,576 6 18 64 351 
SM Nonmedicinal agent causing toxic effects 74 0 6 15 55 
SN Other and unspecified external effect causes 20,989 0 0 15 56 
SP Surgical and medical care complications NEC 32,534 0 0 5 15 
SQ Open wounds involving multiple body regions 13 0 0 0 0 
SR Injury involving multiple body regions 281 0 0 0 0 
Sy [X] Injury and poisoning classification terms 145 0 0 13 26 
Sz Injury and poisoning NOS 1,229 0 0 0 2 
Causes of injury/poisoning    
T0 Railway accidents NA NA NA NA NA 
T1 Motor vehicle traffic accidents (MVTA) 15,993 0 0 9 33 
T2 Motor vehicle non-traffic accident, MVNTA NA NA NA NA NA 
T3 Other road vehicle accidents 2,168 0 0 9 20 
T4 Water transport accidents NA NA NA NA NA 
T5 Air and space transport accidents 15 0 0 5 1746 
T6 Vehicle accidents not elsewhere classifiable NA NA NA NA NA 
T7 Place of occurrence of accident or poisoning 1,223 0 0 0 0 
T8 Accidental poisoning by drugs, medicines and biologicals 132 4 10 20 52 
T9 Accidental poisoning by other non-drug substances 28 0 4 15 31 
TA Medical accidents to patients during surgical/medical care 26 0 0 35 56 
TB Medical + surgical procedures causing complications,no blame 63 0 0 4 21 
TC Accidental falls 94,954 0 0 6 15 
TD Accidents caused by fire and flames NA NA NA NA NA 
TE Accidents due to natural and environmental factors 13,867 0 0 3 9 
TF Accidents caused by submersion, suffocation, foreign bodies 35 0 2 9 24 
TG Other accidents 2,791 0 0 16 61 
TH Late effects due to accidental injury NA NA NA NA NA 
TJ Drugs and other substances-adverse effects in theraputic use 8,008 0 0 0 1 
TK Suicide and selfinflicted injury 1,764 6 17 71 565 
TL Homicide and injury purposely inflicted by other persons 618 0 0 9 29 
TM Legal intervention causing injury NA NA NA NA NA 
TN Injury undetermined whether accidentally/purposely inflicted 29 0 0 14 50 
TP Injury resulting operations of war 14 0 0 7 1442 
Tz Causes of injury and poisoning NOS NA NA NA NA NA 
External causes of morbidity and mortality   
U0 [X]Transport accidents 91 0 0 0 8 
U1 [X]Other external causes of accidental injury 422 0 0 7 18 
U2 [X]Intentional self-harm 1,510 4 13 48 258 
U3 [X]Assault 6,762 0 3 12 37 
U4 [X]Event of undetermined intent 7 0 0 17 17 
U5 [X]Legal intervention and operations of war NA NA NA NA NA 
U6 [X]Complications of medical and surgical care 913 0 0 0 0 
U7 [X]Sequelae of external causes of morbidity and mortality NA NA NA NA NA 
U8 [X]Supplem factr relat to caus morbid+mortal classf elswhere NA NA NA NA NA 
Unspecified conditions     
Z1 Nursing care 189,608 0 0 0 0 
Z2 Pregnancy, childbirth and puerperium observations 5,489 0 4 26 109 
Z3 Child health procedures 1,326 4 20 78 150 
Z4 Counselling 495,856 0 0 0 0 
Z5 Psychotherapy 2,451 0 0 4 13 
Z6 Physiotherapy 34,965 0 0 2 6 
Z7 Occupational therapy 6,190 0 4 20 39 
Z8 Ability to perform personal care activity 1,935 0 0 4 18 
Z9 Indirect care procedures 90,027 0 0 11 29 
ZA Podiatry service 12,202 0 0 1 7 
ZB Orthoptic treatment 42 15 49 87 114 
ZC Feeding and dietary regimes 9,489 0 0 11 20 
ZD Speech and language therapy 380 7 21 49 78 
ZE Hearing observations 1,751 0 0 21 42 
ZF Audiological test observations 20 0 12 39 77 
ZG Advice 121,266 0 0 1 8 
ZH Surveillance 31,763 0 1 5 12 
ZI Physical and psychosocial approaches 64 1 7 10 15 
ZJ Complementary therapy 1,874 0 0 0 0 
ZK Social services procedures 31 0 1 9 13 
ZL Administrative statuses 1,018,247 2 11 24 41 
ZM Ability to perform domestic activities 1,142 0 0 10 29 
ZN Ability to perform community living activities 1,284 0 0 10 29 
ZO Ability to mobilise 100 0 0 7 20 
ZP Education and schooling 117 0 8 28 90 
ZQ Assessment regimes 98,673 0 0 0 3 
ZR Assessment scales 6,222 0 12 38 82 
ZS Speech and language disorder 1,328 0 14 40 77 
ZT Speech and language observations 154 0 0 13 20 
ZU Family details and household composition 552 0 0 8 236 
ZV [V]Health status and contact with health services factors 916,355 0 0 0 7 
ZW Care and support circumstances and networks 187 0 2 39 67 
Zw [Q] Temporary qualifying terms NA NA NA NA NA 
ZX Self-harm 653 3 9 27 53 
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